IYCMI: CALQUENCE Has Received US FDA Approval to Benefit Adults with CLL
source: pixabay.com

IYCMI: CALQUENCE Has Received US FDA Approval to Benefit Adults with CLL

  A recent article in BioPortfolio carried AstraZeneca’s announcement of the FDA’s approval of CALQUENCE® (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The approval…

Continue Reading IYCMI: CALQUENCE Has Received US FDA Approval to Benefit Adults with CLL
Study Finds Increased Risk of Bladder Problems for Primary Sjögren’s Syndrome Patients
source: pixabay.com

Study Finds Increased Risk of Bladder Problems for Primary Sjögren’s Syndrome Patients

A recent study published in the scientific journal PLOS One has determined that patients with the rare disorder primary Sjögren's syndrome are at a greater risk of bladder problems than previously thought.…

Continue Reading Study Finds Increased Risk of Bladder Problems for Primary Sjögren’s Syndrome Patients
CRISPR/Cas9 Looks Promising for Transfusion Dependent Sickle Cell Disease and Beta Thalassemia Patients 
source: pixabay.com

CRISPR/Cas9 Looks Promising for Transfusion Dependent Sickle Cell Disease and Beta Thalassemia Patients 

   CRISPR/Cas9 technology reached another milestone with encouraging results in two recent trials of CTX001. An article in Pharmaceutical Technology carried an announcement by CRISPR Therapeutics and Vertex Pharmaceuticals about…

Continue Reading CRISPR/Cas9 Looks Promising for Transfusion Dependent Sickle Cell Disease and Beta Thalassemia Patients 

New App Could Monitor Disease Progression Simply by Recording Patient’s Speech

A team of cross-disciplinary researchers at Arizona State University (ASU) is working to develop a software which patients with neurological disorders may easily use to assess their disease progression. Through…

Continue Reading New App Could Monitor Disease Progression Simply by Recording Patient’s Speech
XLA: This Father Helped Identify the Disease That Killed His First-Born Son—and Saved His Youngest in the Process
source: pixabay.com

XLA: This Father Helped Identify the Disease That Killed His First-Born Son—and Saved His Youngest in the Process

According to a story from USA Today, Thanksgiving 2009 was a harrowing time for the Anderson family. About a month earlier, Darrin and Sarah Anderson's oldest son Henry had died…

Continue Reading XLA: This Father Helped Identify the Disease That Killed His First-Born Son—and Saved His Youngest in the Process
First Patient Dosed with Experimental Treatment for Multiple Myeloma in Clinical Trial
source: pixabay.com

First Patient Dosed with Experimental Treatment for Multiple Myeloma in Clinical Trial

According to a story from Myeloma Research News, the first patient has been dosed with an experimental allogeneic (donor derived) CAR-T cell therapy called UCARTCS1 as part of a phase…

Continue Reading First Patient Dosed with Experimental Treatment for Multiple Myeloma in Clinical Trial